Assignee
AZEVAN PHARMACEUTICALS INC
US·9 granted patents·5 pending applications·63 citations·filing 2002–2023
Top patents by PatentIndex Score
14 records- 0192US7268125B2β-lactamyl vasopressin V1a antagonistsAZEVAN PHARMACEUTICALS INC·Filed 2006·Granted Sep 11, 2007·19 cites·70 claims
- 0291US9802925B2Compositions and methods for treating neurodegenerative diseasesAZEVAN PHARMACEUTICALS INC·Filed 2015·Granted Oct 31, 2017·4 cites·32 claims
- 0387US10364236B2Compositions and methods for treating neurodegenerative diseasesAZEVAN PHARMACEUTICALS INC·Filed 2017·Granted Jul 30, 2019·2 cites·22 claims
- 0487US8048874B2Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonistsAZEVAN PHARMACEUTICALS INC·Filed 2006·Granted Nov 1, 2011·10 cites·22 claims
- 0587US7119083B2β-Lactamyl vasopressin V1a AntagonistsAZEVAN PHARMACEUTICALS INC·Filed 2002·Granted Oct 10, 2006·22 cites·70 claims
- 0682US9987265B2Methods for treating post traumatic stress disorderAZEVAN PHARMACEUTICALS INC·Filed 2016·Granted Jun 5, 2018·3 cites·19 claims
- 0780US10953001B2Methods for treating post traumatic stress disorderAZEVAN PHARMACEUTICALS INC·Filed 2018·Granted Mar 23, 2021·2 cites·23 claims
- 0876US2023123729A1Compositions and methods for treating neurodegenerative diseasesAZEVAN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0975US11628160B2Compositions and methods for treating brain injuryAZEVAN PHARMACEUTICALS INC·Filed 2018·Granted Apr 18, 2023·1 cites·8 claims
- 1069US2024115553A1Compositions and methods for treating brain injuryAZEVAN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1165US2008090797A1{Beta}-Lactamyl vasopression V1a antagonists and methods of useAZEVAN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1265US2008113959A1{Beta}-Lactamyl vasopression V1a antagonists and methods of useAZEVAN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1362US11319306B2Compositions and methods for treating neurodegenerative diseasesAZEVAN PHARMACEUTICALS INC·Filed 2019·Granted May 3, 2022·0 cites·10 claims
- 1455US2011059935A1Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTSAZEVAN PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AZEVAN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →